New Zealand Shares Flat; Taiko Critical Minerals Secures Nearly NZ$8 Million in Capital Raise

MT NewswiresApr 29 13:34

TCM Group Announces Financial Outlook for 2026

GlobeNewswireFeb 26 00:35

IPO News | Wen Zhi Traditional Chinese Medicine's Hong Kong IPO prospectus has expired.

The Hong Kong stock prospectus submitted by Wen Zhi Traditional Chinese Medicine on July 29, 2025, expired on January 29, 2026, six months after its submission. Haitong International was the exclusive sponsor at the time of filing. This marks the second expiration of the company's listing application.

Zhitong FinanceJan 29 11:15

Wen Zhi Chinese Medicine Opens the Door to Capital Markets: How Will the 'First TCM AI Stock' Reshape the TCM Diagnosis and Treatment Paradigm?

On August 26, 2025, the State Council's "Guiding Opinions on Deepening the Implementation of the 'Artificial Intelligence+' Action" was officially released. Amid the wave of the fourth industrial revolution led by artificial intelligence, the integration of 'AI + Traditional Chinese Medicine (TCM)' is not only an inevitable trend in the modernization of TCM but also a cognitive upgrade that practitioners of TCM must undertake. In August 2025, Wenzhi TCM officially submitted its updated prospectus to the Hong Kong Stock Exchange, marking a key step towards becoming the first publicly listed company in the 'TCM AI' sector. The updated prospectus shows that between 2022 and 2024, Wenzhi TCM’s revenue grew from RMB 62.169 million to approximately RMB 236 million, with the first five months of 2025 showing further growth.

China InvestorsOct 10, 2025 15:58

Change in Executive Management – TCM Group Appoints New CFO.

GlobeNewswireAug 29, 2025 14:00

HK IPO Weekly Report | A-share lithium battery giant Sunwoda Electronic files for listing; riding the wave of innovative drug enthusiasm, innovative vaccine company Zhonghui Biology-B to debut on HKEX next Friday.

Sunwoda Electronic, a lithium battery company listed on the A-share market, has submitted its application. What are the key highlights of the company's performance? ② Zhonghui Biological has passed the listing hearing and initiated its IPO. What are the details?

cls.cnAug 3, 2025 16:36